⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRLD News
Prelude Therapeutics Incorporated
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
Prelude Therapeutics Announces Strategic Business Update
globenewswire.com
PRLD
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
globenewswire.com
PRLD
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
globenewswire.com
PRLD
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
globenewswire.com
PRLD